Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists

Details for Australian Patent Application No. 2004251823 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Gijsen, Henricus Jacobus Maria; Mevellec, Laurence Anne; Bosmans, JeanPaul Rene Marie Andre

Agent Shelston IP

Pub. Number AU-B-2004251823

PCT Pub. Number WO2005/000837

Priority PCT/EP03/50238 19.06.03 EP

Filing date 10 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 3 June 2010

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/453 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/000837 Priority application(s): WO2005/000837

3 June 2010 Application Accepted

  Published as AU-B-2004251823

30 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251825-4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists

2004251814-Benzothiazole derivatives as adenosine receptor ligands